KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for AbbVie (ABBV) over the last 14 years, with Q3 2025 value amounting to -$4.6 billion.

  • AbbVie's Cash from Financing Activities fell 4941.41% to -$4.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$15.4 billion, marking a year-over-year decrease of 45087.53%. This contributed to the annual value of -$5.2 billion for FY2024, which is 6974.22% up from last year.
  • AbbVie's Cash from Financing Activities amounted to -$4.6 billion in Q3 2025, which was down 4941.41% from -$2.7 billion recorded in Q2 2025.
  • AbbVie's 5-year Cash from Financing Activities high stood at $10.8 billion for Q1 2024, and its period low was -$9.6 billion during Q4 2022.
  • Its 5-year average for Cash from Financing Activities is -$3.9 billion, with a median of -$4.4 billion in 2023.
  • In the last 5 years, AbbVie's Cash from Financing Activities tumbled by 12894.94% in 2021 and then skyrocketed by 27472.55% in 2024.
  • AbbVie's Cash from Financing Activities (Quarter) stood at -$6.3 billion in 2021, then tumbled by 52.0% to -$9.6 billion in 2022, then soared by 53.82% to -$4.4 billion in 2023, then tumbled by 54.21% to -$6.9 billion in 2024, then soared by 33.1% to -$4.6 billion in 2025.
  • Its last three reported values are -$4.6 billion in Q3 2025, -$2.7 billion for Q2 2025, and -$1.3 billion during Q1 2025.